Vera Therapeutics Inc. (VERA)
NASDAQ: VERA
· Real-Time Price · USD
21.90
-1.06 (-4.62%)
At close: Sep 04, 2025, 3:59 PM
21.90
0.00%
Pre-market: Sep 05, 2025, 08:49 AM EDT
-4.62% (1D)
| Bid | 21 |
| Market Cap | 1.4B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -218.28M |
| EPS (ttm) | -3.59 |
| PE Ratio (ttm) | -6.1 |
| Forward PE | -5.09 |
| Analyst | Buy |
| Ask | 23.5 |
| Volume | 1,174,280 |
| Avg. Volume (20D) | 1,659,122 |
| Open | 22.90 |
| Previous Close | 22.96 |
| Day's Range | 21.71 - 22.97 |
| 52-Week Range | 18.53 - 51.61 |
| Beta | 1.16 |
About VERA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VERA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VERA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+67.49%
Vera Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
7 months ago
-6.08%
Vera Therapeutics shares are trading lower. The company announced an exclusive license agreement with Stanford University for VT-109.
